More: 15th Conference on Retroviruses and Opportunistic Infections (CROI)

CROI 2008: Management of HIV Infection in Special Populations CME

February 3 - 6, 2008, Boston, Massachusetts

Author Information and Disclosures

This activity is not sanctioned by, nor a part of, the 15th Conference on Retroviruses and Opportunistic Infections.

Release Date: March 18, 2008Valid for credit through March 18, 2009

Credits Available
Physicians - maximum of 0.75 AMA PRA Category 1 Credit(s) for physicians

To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.

Contents of This CME Activity

  1. HIV/Hepatitis Virus Coinfections
  2. Preventing Mother-to-Child Transmission and Pediatric HIV

Legal Disclaimer

The materials presented here do not reflect the views of Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity.

The materials presented here were prepared by independent authors under the editorial supervision of Medscape and do not represent a publication of the 15th Conference on Retroviruses and Opportunistic Infections. These materials and the related activity are not sanctioned by the 15th Conference on Retroviruses and Opportunistic Infections or the commercial supporter of the conference and do not constitute an official part of that conference.

Copyright © 2008 Medscape.


GlaxoSmithKline

Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Review current HIV management guidelines for patients with hepatitis coinfections
  2. Update clinical practice by incorporating novel data regarding vertical transmission as presented at CROI
  3. Discuss the most effective means of assessing risk and preventing and managing vertical transmission of HIV infection
Authors and Disclosures

Glenda G.E. Gray, MD, MBBCH, FCPaeds
Disclosure: Glenda G.E. Gray, MD, MBBCH, FCPaeds, has disclosed that she has served as an advisor to GlaxoSmithKline and Merck.


Vincent V. Soriano, MD, PhD
Disclosure: Vincent V. Soriano, MD, PhD, has disclosed that he has received grants for clinical research and educational activities from, and has served as an advisor or consultant to, Schering-Plough, Roche, Bristol-Myers Squibb, and Gilead.


Thomas Maxwell Mundy, MD
Disclosure: Thomas Maxwell Mundy, MD, has disclosed no relevant financial relationships.


 
Medscape
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this educational activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.